Singapore: China based biotech firm, 3SBio, has partnered with Selecta Biosciences to license out pegsiticase (Uricase P...
Singapore: Patrys, an Australian clinical stage biopharmaceutical company, has completed the initial treatment of the fi...
Singapore: GVK Bio and US-based Onconova Therapeutics entered into a novel joint partnership to develop new drugs for c...
Singapore: Asian Myeloma Network is developing a regional collaboration of medical specialists across Asia to study the ...
Bangalore: New data from a subgroup analysis of the A1chieve study showed that intensifying treatment with NovoMix 30 (B...
Singapore: Boehringer Ingelheim has initiated phase III study (POLO-AML-2) investigating volasertib, a selective and pot...
Singapore: Takeda Global Research & Development Center resubmitted New Drug Applications (NDAs) to the US FDA for al...
Singapore: Phylogica, a public Australian peptide drug discovery company, has achieved a research milestone under its co...
Singapore: Gilead Sciences has successfully progressed phase IV Terisa (Type 2 Diabetes Evaluation of Ranolazine in subj...
Singapore: Global Pharmaceutical company, AstraZeneca plans to integrate Dendrimer drug delivery technology developed by...
Singapore: Mundipharma, global pharmaceutical company with operations in Singapore, has entered into a license agreement...
Singapore: TNI BioTech and Hubei Qianjiang Pharmaceutical, a leading Chinese pharmaceutical company will co-develop new...
Singapore: Drug Discovery company, Evotec has inked a research collaboration and licensing deal with Swiss Pharma compan...
Singapore: Researchers from St Vincent's Institute of Medical Research in Melbourne, Australia, in collaboration with re...
Singapore: Agilent Technologies has introduced the Agilent Automated Card Extraction LC/MS system, a fully integrated in...
Singapore: AMRI has signed a definitive agreement to acquire all the outstanding shares of Cedarburg Pharmaceuticals for...
As a scientist-turned entrepreneur, my journey has taken a long time, with many struggles along the way. For an entrepre...
Singapore: US Food and Drug Administration (FDA) has approved Novartis' Xolair (omalizumab) for the treatment of chronic...
